Logo

Sensigen Lands Loan from Michigan Economic Development Group

Feb 21, 2008
NEW YORK (GenomeWeb News) – Molecular diagnostics company Sensigen said today it plans to use a loan at 1 percent interest from the Michigan Economic Development Corporation to expand its operations in Ann Arbor.
 
The company, which is developing diagnostic tests for human papillomavirus, chronic kidney disease, lupus, and other diseases, will use the money from the loan to hire workers that have been displaced by the closing of a Pfizer facility in Michigan.
 
The company’s molecular diagnostics technology, which combines mass spectrometry and PCR, was developed by University of Michigan researcher David Kurnit.
 
MEDC is a partnership between the State of Michigan and local communities that promote economic growth and development strategies.
 
Further terms of the loan agreement were not released.

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.